Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

about

Case-control study of metabolic syndrome and ovarian cancer in Chinese population Circulating Serum Level of Visfatin in Patients with Endometrial Cancer.Metformin as a Therapeutic Target in Endometrial Cancers

P2860

Q29248169-2CB0058B-6F38-4039-8763-40D7204C73D3 Q55283343-64F33E52-E75F-4371-950C-F52B6A32E9B3 Q58698115-7E5D6BBB-FEB3-4DFB-A39D-8C28978DC7B5

P2860

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

Item

http://www.wikidata.org/entity/Q41495484

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

@en

type

Item

label

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

@en

prefLabel

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

@en

P1476

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

@en

P2093

A Yu

http://www.w3.org/2001/XMLSchema#string

F Che

http://www.w3.org/2001/XMLSchema#string

H Shou

http://www.w3.org/2001/XMLSchema#string

J Ni

http://www.w3.org/2001/XMLSchema#string

L Zhao

http://www.w3.org/2001/XMLSchema#string

T Zhu

http://www.w3.org/2001/XMLSchema#string

Y Chen

http://www.w3.org/2001/XMLSchema#string

P2860

Metabolic abnormalities and risk for colorectal cancer in the physicians' health study

Overweight, obesity and cancer: epidemiological evidence and proposed mechanisms

Theories of endometrial carcinogenesis: a multidisciplinary approach.

Role of progesterone in endometrial cancer

Hormonal interactions in endometrial cancer.

Metabolic syndrome--a new world-wide definition. A Consensus Statement from the International Diabetes Federation.

Two pathogenetic types of endometrial carcinoma.

A prospective evaluation of insulin and insulin-like growth factor-I as risk factors for endometrial cancer.

Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; Internat

The metabolic syndrome: A high-risk state for cancer?

P2888

s12094-015-1309-8

P304

835-839

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S12094-015-1309-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26260911

http://www.w3.org/2001/XMLSchema#string

P921

metabolic syndrome

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

about

P2860

P2860

Metabolic syndrome is an independent prognostic factor for endometrial adenocarcinoma.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P577

P698

P921